Sirturo
Active Ingredient(s): BedaquilineFDA Approved: * December 28, 2012
Pharm Company: * JANSSEN R AND D
Category: Tuberculosis
Bedaquiline, sold under the brand name Sirturo, is a medication used to treat active tuberculosis.[1] Specifically, it is used to treat multi-drug-resistant tuberculosis (MDR-TB) along with other medications for tuberculosis.[1][5][6] It is used by mouth.[7] Common side effects include nausea, joint pains, headaches, and chest pain.[1] Serious side effects include QT prolongation, liver dysfunction... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.